Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$10,439,426
-$2,088,297 QoQ
Shares Held
433,531
-2.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#415
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rathbones Group PLC holds $2,298,575,113 across 12 Drug Manufacturers - General names. PFE ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,979,150 | $1,513,006,423 | |
| 2 | LLY |
ELI LILLY & Co
|
447,654 | $536,929,681 | |
| 3 | JNJ |
Johnson & Johnson
|
691,961 | $175,737,335 | |
| 4 | MRK |
Merck & Co., Inc.
|
207,542 | $26,669,147 | |
| 5 | ABBV |
AbbVie Inc.
|
65,288 | $16,429,072 | |
| 6 | PFE |
Pfizer Inc
This page
|
433,531 | $10,439,426 | |
| 7 | AMGN |
Amgen Inc
|
20,628 | $7,469,811 | |
| 8 | NVS |
Novartis AG
|
43,692 | $6,847,410 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,439,426 | 433,531 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $12,527,723 | 446,144 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,143,372 | 447,525 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $12,091,151 | 474,535 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $11,817,678 | 487,528 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $14,203,450 | 560,515 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $15,521,562 | 585,057 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,511,333 | 605,091 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,672,106 | 595,858 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $16,573,965 | 597,260 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $17,395,551 | 604,222 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $21,081,127 | 635,548 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $18,055,693 | 492,249 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $20,332,924 | 498,356 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,339,819 | 514,048 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,913,607 | 500,768 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $28,030,126 | 534,620 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $27,084,200 | 523,164 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $31,287,878 | 529,854 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $22,827,729 | 530,754 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $23,393,244 | 597,376 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $22,459,266 | 619,908 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $24,890,811 | 676,197 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $24,764,731 | 674,789 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $20,008,104 | 611,868 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $20,498,088 | 628,006 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||